ALTS vs ASML

ALTS exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating poor operational and financial health. The company's Altman Z-Score is unavailable, but its negative ROA (-1.71%), negative operating margin (-218.34%), and extremely low current ratio (0.80) suggest high bankruptcy risk. Despite strong revenue growth (53.3% YoY), profitability remains elusive, and the stock trades at a steep Price/Sales of 6.85, far above its low Price/Book of 0.11. The 52-week price range ($1.08–$10.95) and 5-year decline of 82.8% reflect deep investor skepticism, despite a single 'strong_buy' analyst recommendation.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.